InnovAge Holding Corp logo

InnovAge Holding Corp(INNV)

upturn advisory logo
EXPLORE ADVISORIES AND THEIR HISTORY
QUALITY SIGNAL
4-STAR RATING
PASS
LAST CLOSE
$9.47
11/13/2026
(24-hour delay)

Advisory History & Simulated Performance *

*as per simulation (see disclosures)
  • ALL
  • 1Y
  • 1M
  • 1W
  • BUY Advisory
  • SELL Advisory (Profit)
  • SELL Advisory (Loss)
  • Profit
  • Loss
  • PASS (Skip)
Upturn Stock price based on last close iconStock price based on last close
Simulated performance—not actual client returns. Excludes advisory subscription fees, trading commissions, and taxes, which would reduce returns. Results depend on calculation assumptions and do not guarantee future outcomes. See Disclosures for full methodology, assumptions, and limitations.

Advisory Performance History (Simulated)Advisory Performance History info

Simulated performance—not actual client returns. Excludes advisory subscription fees, trading commissions, and taxes, which would reduce returns. Results depend on calculation assumptions and do not guarantee future outcomes. See Disclosures for full methodology, assumptions, and limitations.

Upturn Advisory & Investor View for INNV

11/13/2026: INNV (4-star) is currently NOT-A-BUY. Pass it for now.

InnovAge Holding Corp is a healthcare services provider specializing in the Program of All-Inclusive Care for the Elderly (PACE), offering integrated medical and social care to frail seniors. The company has a unique focus on a high-need demographic and utilizes a capitated payment model to deliver comprehensive long-term care. While the firm has significant growth opportunities driven by an aging population and its scalable PACE model, it has faced substantial operational and regulatory challenges that hindered recent performance. Investors should closely monitor regulatory compliance, enrollment growth in new centers, and margin stability. It is best suited for investors comfortable with high-risk scenarios and long-term sector growth stories.

How to Read the Upturn Advisory

The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.

Company fundamentals, valuation, risks, and news provide supporting context about the business.

Investor Fit

Investor styleFitWhy
Growth investorMixed fitThe company offers exposure to aging-population tailwinds but faces significant execution and regulatory recovery hurdles.
Momentum investorWeak fitThe stock has historically struggled with consistent upward price momentum due to operational headwinds.
Value investorMixed fitWhile valuation may appear compressed, the underlying business risks require a careful assessment of long-term profitability.
Dividend investorWeak fitThe company does not pay a dividend and is currently focused on capital retention for operations.
Low-risk investorWeak fitHigh regulatory and operational volatility makes this stock unsuitable for conservative, risk-averse portfolios.

Risk Profile

Risk factorLevelWhy it matters
Price volatilityHighThe stock is susceptible to sharp swings based on regulatory news and enrollment updates.
Valuation riskMedium / highValuation depends heavily on the company's ability to restore long-term growth and stable margins.
Competition risk (PACE and Managed Care)MediumCompetition from well-capitalized insurers puts pressure on enrollment and talent acquisition.
Business qualityMediumThe company provides a critical service but must demonstrate sustained operational stability.
Dividend incomeLow / noneInvestors receive no current income from holding this stock.
Execution riskHighSuccessfully managing enrollment capacity and regulatory compliance is paramount to the firm's survival and growth.

Key Highlights

Company Size Small-Cap Stock
Market Capitalization 1.29B USD
Price to earnings Ratio 157.83
1Y Target Price 12
Price to earnings Ratio 157.83
1Y Target Price 12
Volume (30-day avg) 565.4K shares
Beta 0.19
52 Weeks Range 4.70 - 12.64
Updated Date 11/13/2026
52 Weeks Range 4.70 - 12.64
Updated Date 11/13/2026
Dividends yield (FY) -
Basic EPS (TTM) 0.06

Sector & Industry Intelligence

Sector

Healthcare

Bullish
Sentiment
Strong Bullish
Momentum
Momentum Steady
BUY participation
62.6%
Active BUY / eligible
72 / 115
30-Day BUY Count Change
+35
Market state
Strong Bullish

The number of qualifying BUY stocks has remained relatively stable.

Industry

Medical Care Facilities

BUY participation
88.9%
Active BUY / eligible
8 / 9
30-Day BUY Count Change
+6

Sector signal summarizes BUY breadth conditions for the sector. It does not override this stock’s BUY, SELL, or PASS advisory.

Price Behavior

Rolling Over
PRICE PATH

Rolling Over

The price momentum is slowing down and beginning to turn downward.

Choppy
PRICE STABILITY

Choppy

The stock has experienced frequent reversals and pronounced short-term price swings.

Analysis of Past Performance

Type Stock
Historic Profit 76.14%
Avg. Invested days 42
Today’s Advisory PASS
Upturn Advisory Rating upturn star rating icon
Upturn Advisory Performance Upturn Advisory Performance icon 5.0
Stock Returns Performance Upturn Returns Performance icon 4.0
Upturn Profits based on simulation icon Profits based on simulation
Upturn last close icon Last Close 11/13/2026

Upturn Scorecard

Upturn Star Rating

★★★★★
INNV receives a 3-star rating based on the available scored pillars. The rating is constrained by weak unit economics, and weak price momentum.

Company Fundamentals

★★★★★
INNV has moderate overall fundamentals (3 stars), with moderate financial health, solid growth momentum, and moderate ownership. In FY2026 versus FY2025, strong earnings growth (+91.6%) and solid cash generation (FCF margin 5.1%) are partially offset by weak profitability (net margin -0.3%).

Financial Health Rating

★★★★★
INNV's financial health is supported by moderate cash strength, including free-cash-flow generation (5.1% of revenue). Profitability is soft (2 stars), which helps explain the 3-star overall score.

Growth Momentum Score

★★★★★
Earnings growth is INNV's strongest growth driver at +91.6% FY2026 versus FY2025 (strong, 5 stars). Revenue growth (+15.9%, solid) and free-cash-flow growth (+89.5%, strong) are also constructive, though not equally high across every growth measure.

Ownership

★★★★★
Institutional ownership is 16.4% (soft) and 25.2% of outstanding shares are publicly tradable (soft). Insider ownership of 74.90% supports management-shareholder alignment.

Top 5 Institutional Investors

T. Rowe Price Investment Management,Inc. 4.49%
Federated Hermes Inc 1.40%
BlackRock Inc 1.09%
Vanguard Capital Management, LLC 0.69%
Arrowstreet Capital Limited Partnership 0.49%

Unit Economics (Per $1K Revenue)

★★★★★
INNV generates approximately $209 of gross profit, $67 of operating income, and $51 of free cash flow for every $1,000 of revenue. Based on FY2026 results. Soft margins explain the 1-star rating, with weak cash conversion and weak capital efficiency.

Economic Dimensions

★★★★★
Effective Tax Rate: 356.77%

Quantitative Style Profile

★★★★★
INNV has a relatively low-volatility profile. Weak momentum is the primary drawback, while valuation that is moderately attractive rather than deeply discounted.

Style Classification

Quality Focused

Low VolatilitySmall / Mid Cap Risk

How Company Makes Money

Business areaWhat it includesRetail investor read
PACE ProgramCapitated payments for providing comprehensive health and social services to frail seniors.The company gets paid a set monthly fee to manage all of a senior's medical needs, aiming to keep them healthy and out of nursing homes.

Analyzing Revenue: Products, Geography and Growth

Revenue by Products

Product revenue - Year on Year

Revenue by Geography

Geography revenue - Year on Year

Earnings Date

Report Date 2026-11-03
When After Market
Estimate 0.11
Actual 0.14

Profitability

Profit Margin 0.88%
Operating Margin (TTM) 1.72%

Management Effectiveness

Return on Assets (TTM) 2.04%
Return on Equity (TTM) 4.43%

Valuation

Trailing PE 157.83
Forward PE 13.66
Enterprise Value 1.20B
Price to Sales(TTM) 1.27
Enterprise Value 1.20B
Price to Sales(TTM) 1.27
Enterprise Value to Revenue 1.18
Enterprise Value to EBITDA 32.33
Shares Outstanding 136.46M
Shares Floating 34.40M
Shares Outstanding 136.46M
Shares Floating 34.40M
Percent Insiders 74.9
Percent Institutions 16.37

Financial Metrics

🧭 Investment Snapshot

Total Revenue (Scale)

Information icon Total money earned from selling products or services before any costs. It is needed to understand the scale of the business and its ability to generate income.

Net Income (Profit)

Information icon Final profit after all expenses, interest, and taxes are deducted. It is needed to determine the overall profitability available to shareholders.

Free Cash Flow (Cash Strength)

Information icon Cash remaining after operating activities and capital expenditures, showing cash available for growth. It is needed to evaluate the company’s ability to invest, pay dividends, or reduce debt.

📈 Growth & Strength

Operating Income (Core Profit)

Information icon Profit from core operations after deducting all operating expenses. It is needed to measure how efficiently the company runs its primary business activities.

EBITDA (Cash Earnings)

Information icon Earnings before interest, taxes, depreciation, and amortization, indicating operating cash potential. It is needed to compare operating performance across companies without accounting or financing differences.

Gross Profit (Unit Profitability)

Information icon Revenue minus cost of revenue, showing profit after direct production costs. It is needed to evaluate core business profitability before overhead expenses.

🛡️ Financial Safety

Cash (Liquidity Buffer)

Information icon Total cash and cash equivalents on hand. It is needed to evaluate immediate liquidity and financial flexibility.

Total Debt (Leverage Risk)

Information icon Total debt including both short-term and long-term components. It is needed to assess the company’s leverage and financial risk.

Net Working Capital (Short-Term Health)

Information icon Current assets minus current liabilities, indicating short-term liquidity strength. It is needed to assess whether the company can meet its short-term obligations.

🧱 Balance Sheet Strength

Stockholder Equity (Net Worth)

Information icon Total equity value held by shareholders. It is needed to understand the net worth of the company from the owners’ perspective.

Total Assets (Asset Base)

Information icon The full value of everything the company owns, including cash, inventory, equipment, and investments. It is needed to understand the resource base used to generate revenue.

Income Before Tax (Pre-Tax Earnings)

Information icon Income before provision for income taxes. It is needed to analyze profitability independent of tax structures.

⚙️ Cost & Drag Factors

Cost of Revenue (Production Cost)

Information icon Direct costs required to produce and deliver the products or services sold. It is needed to assess efficiency in production and service delivery.

Total Operating Expenses (Operating Cost)

Information icon Indirect costs of running the business such as salaries, marketing, and administration. It is needed to understand how much it costs to sustain ongoing business operations.

Income Tax Expense (Tax Drag)

Information icon Amount of taxes paid or payable to the government. It is needed to evaluate the impact of taxation on overall profitability.

Form CRS provides a relationship summary of our automated advisory services, flat subscription fees, and conflicts of interest. Form ADV Part 2A brochure contains complete details on services, billing, and disclosures. If any summary differs from our current regulatory filings, the filed Form ADV controls.